Great West Life Assurance Co. Can lowered its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 5.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 35,040 shares of the industrial products company’s stock after selling 1,848 shares during the period. Great West Life Assurance Co. Can owned approximately 0.13% of Proto Labs worth $2,763,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of PRLB. Russell Investments Group Ltd. lifted its holdings in Proto Labs by 25.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 16,501 shares of the industrial products company’s stock worth $1,110,000 after buying an additional 3,337 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Proto Labs by 2.7% during the 2nd quarter. Vanguard Group Inc. now owns 2,176,051 shares of the industrial products company’s stock worth $146,339,000 after buying an additional 56,724 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in Proto Labs by 411.4% during the 2nd quarter. Janus Henderson Group PLC now owns 1,301,429 shares of the industrial products company’s stock worth $87,521,000 after buying an additional 1,046,960 shares in the last quarter. Daiwa Securities Group Inc. acquired a new stake in Proto Labs during the 3rd quarter worth approximately $915,000. Finally, Victory Capital Management Inc. lifted its holdings in Proto Labs by 15,548.3% during the 3rd quarter. Victory Capital Management Inc. now owns 363,509 shares of the industrial products company’s stock worth $29,190,000 after buying an additional 361,186 shares in the last quarter.

In related news, VP John B. Tumelty sold 13,556 shares of Proto Labs stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $92.07, for a total transaction of $1,248,100.92. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Rainer Gawlick sold 1,500 shares of Proto Labs stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $90.31, for a total transaction of $135,465.00. Following the sale, the director now owns 6,925 shares in the company, valued at $625,396.75. The disclosure for this sale can be found here. Insiders sold a total of 19,056 shares of company stock worth $1,762,726 over the last 90 days. Company insiders own 7.78% of the company’s stock.

Shares of Proto Labs, Inc. (PRLB) traded up $3.45 on Thursday, hitting $99.30. 158,200 shares of the stock were exchanged, compared to its average volume of 192,835. Proto Labs, Inc. has a fifty-two week low of $48.00 and a fifty-two week high of $99.85. The firm has a market cap of $2,554.00, a price-to-earnings ratio of 54.77, a price-to-earnings-growth ratio of 2.40 and a beta of 1.06.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings data on Thursday, October 26th. The industrial products company reported $0.56 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.04. Proto Labs had a net margin of 14.53% and a return on equity of 11.63%. The business had revenue of $88.10 million for the quarter, compared to analyst estimates of $85.68 million. During the same period last year, the business earned $0.51 EPS. The company’s revenue was up 12.7% on a year-over-year basis. analysts anticipate that Proto Labs, Inc. will post 1.9 earnings per share for the current fiscal year.

A number of research firms have issued reports on PRLB. Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 target price on the stock in a report on Friday, November 3rd. Craig Hallum set a $92.00 target price on shares of Proto Labs and gave the stock a “hold” rating in a report on Monday, November 27th. Finally, BidaskClub lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Friday, October 6th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $75.00.

COPYRIGHT VIOLATION WARNING: This story was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/12/14/proto-labs-inc-prlb-shares-sold-by-great-west-life-assurance-co-can.html.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.